OBJECTIVE: Spinal cord atrophy is prominent in chronic progressive neurologic diseases such as human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS). Here we compared the spinal cord cross-sectional area (SCCSA) in HAM/TSP and MS patients to that of healthy volunteers (HVs). METHODS: SCCSA and clinical disability scores were measured in 18 HAM/TSP patients, 4 asymptomatic carriers (ACs) of HTLV-1, 18 MS patients, and 10 HVs from a 3T magnetic resonance imaging. SCCSA measured in patients and ACs were compared to that of HVs and correlated with disability scores. RESULTS: The entire spinal cord in HAM/TSP patients was thin compared to HVs, whereas only the cervical cord in MS patients was thinner than in HVs (p < 0.0001). In HAM/TSP patients, SCCSA extensively correlated with Ambulation Index, whereas only the cervical cord correlated with disease duration (p < 0.05). In MS patients, the SCCSA extensively correlated with Scripps Neurologic Rating Score and the Expanded Disability Status Scale (p < 0.05). One of the 4 ACs showed atrophy in a pattern similar to HAM/TSP. INTERPRETATION: These results are in accordance with the findings that whereas over half of all lesions in an MS cord are seen in the upper cervical cord, most of the pathology in HAM/TSP is seen in the thoracolumbar cord, which in turn may be responsible for the more extensive cord atrophy seen in HAM/TSP. An imaging marker such as SCCSA might serve as a surrogate endpoint in clinical trials, especially to assess the neuroprotective impact of various therapies.
OBJECTIVE:Spinal cord atrophy is prominent in chronic progressive neurologic diseases such as human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS). Here we compared the spinal cord cross-sectional area (SCCSA) in HAM/TSP and MSpatients to that of healthy volunteers (HVs). METHODS: SCCSA and clinical disability scores were measured in 18 HAM/TSPpatients, 4 asymptomatic carriers (ACs) of HTLV-1, 18 MSpatients, and 10 HVs from a 3T magnetic resonance imaging. SCCSA measured in patients and ACs were compared to that of HVs and correlated with disability scores. RESULTS: The entire spinal cord in HAM/TSPpatients was thin compared to HVs, whereas only the cervical cord in MSpatients was thinner than in HVs (p < 0.0001). In HAM/TSPpatients, SCCSA extensively correlated with Ambulation Index, whereas only the cervical cord correlated with disease duration (p < 0.05). In MSpatients, the SCCSA extensively correlated with Scripps Neurologic Rating Score and the Expanded Disability Status Scale (p < 0.05). One of the 4 ACs showed atrophy in a pattern similar to HAM/TSP. INTERPRETATION: These results are in accordance with the findings that whereas over half of all lesions in an MS cord are seen in the upper cervical cord, most of the pathology in HAM/TSP is seen in the thoracolumbar cord, which in turn may be responsible for the more extensive cord atrophy seen in HAM/TSP. An imaging marker such as SCCSA might serve as a surrogate endpoint in clinical trials, especially to assess the neuroprotective impact of various therapies.
Authors: Min Chen; Aaron Carass; Jiwon Oh; Govind Nair; Dzung L Pham; Daniel S Reich; Jerry L Prince Journal: Neuroimage Date: 2013-08-06 Impact factor: 6.556
Authors: M A Rocca; M A Horsfield; S Sala; M Copetti; P Valsasina; S Mesaros; V Martinelli; D Caputo; T Stosic-Opincal; J Drulovic; G Comi; M Filippi Journal: Neurology Date: 2011-06-14 Impact factor: 9.910
Authors: Francesca Bagnato; John A Butman; Carlos A Mora; Shiva Gupta; Yoshima Yamano; Talin A Tasciyan; Jeffrey M Solomon; Waldyr J Santos; Roger D Stone; Henry F McFarland; Steven Jacobson Journal: J Neurovirol Date: 2005-12 Impact factor: 2.643
Authors: J P Klein; A Arora; M Neema; B C Healy; S Tauhid; D Goldberg-Zimring; C Chavarro-Nieto; J M Stankiewicz; A B Cohen; G J Buckle; M K Houtchens; A Ceccarelli; E Dell'Oglio; C R G Guttmann; D C Alsop; D B Hackney; R Bakshi Journal: AJNR Am J Neuroradiol Date: 2011-04-28 Impact factor: 3.825
Authors: Paola Valsasina; Maria A Rocca; Mark A Horsfield; Martina Absinta; Roberta Messina; Domenico Caputo; Giancarlo Comi; Massimo Filippi Journal: Radiology Date: 2012-11-28 Impact factor: 11.105
Authors: Regina Schlaeger; Nico Papinutto; Alyssa H Zhu; Iryna V Lobach; Carolyn J Bevan; Monica Bucci; Antonella Castellano; Jeffrey M Gelfand; Jennifer S Graves; Ari J Green; Kesshi M Jordan; Anisha Keshavan; Valentina Panara; William A Stern; H-Christian von Büdingen; Emmanuelle Waubant; Douglas S Goodin; Bruce A C Cree; Stephen L Hauser; Roland G Henry Journal: JAMA Neurol Date: 2015-08 Impact factor: 18.302
Authors: Sebastián Quintremil; Carolina Alberti; Matías Rivera; Fernando Medina; Javier Puente; Luis Cartier; Eugenio Ramírez; Yuetsu Tanaka; M Antonieta Valenzuela Journal: AIDS Res Hum Retroviruses Date: 2015-09-21 Impact factor: 2.205
Authors: Yoshimi Enose-Akahata; Breanna Caruso; Benjamin Haner; Emily Charlip; Govind Nair; Raya Massoud; Bridgette J Billioux; Joan Ohayon; William M Switzer; Steven Jacobson Journal: Retrovirology Date: 2016-08-12 Impact factor: 4.602